Titre : Arachidonate 12-lipoxygenase

Arachidonate 12-lipoxygenase : Questions médicales fréquentes

Termes MeSH sélectionnés :

Latent Class Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Arachidonate 12-lipoxygenase : Questions médicales les plus fréquentes", "headline": "Arachidonate 12-lipoxygenase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Arachidonate 12-lipoxygenase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-07", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Arachidonate 12-lipoxygenase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Arachidonate lipoxygenases", "url": "https://questionsmedicales.fr/mesh/D001091", "about": { "@type": "MedicalCondition", "name": "Arachidonate lipoxygenases", "code": { "@type": "MedicalCode", "code": "D001091", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.556.579.374.568.500" } } }, "about": { "@type": "MedicalCondition", "name": "Arachidonate 12-lipoxygenase", "alternateName": "Arachidonate 12-Lipoxygenase", "code": { "@type": "MedicalCode", "code": "D001092", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hartmut Kuhn", "url": "https://questionsmedicales.fr/author/Hartmut%20Kuhn", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany." } }, { "@type": "Person", "name": "Raghavendra G Mirmira", "url": "https://questionsmedicales.fr/author/Raghavendra%20G%20Mirmira", "affiliation": { "@type": "Organization", "name": "Department of Medicine, The University of Chicago, Chicago, IL 60637, USA." } }, { "@type": "Person", "name": "Theodore R Holman", "url": "https://questionsmedicales.fr/author/Theodore%20R%20Holman", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, CA." } }, { "@type": "Person", "name": "Klaus van Leyen", "url": "https://questionsmedicales.fr/author/Klaus%20van%20Leyen", "affiliation": { "@type": "Organization", "name": "Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, United States." } }, { "@type": "Person", "name": "Sabine Stehling", "url": "https://questionsmedicales.fr/author/Sabine%20Stehling", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Latent class analysis of eHealth behaviors among adults with epilepsy.", "datePublished": "2022-12-28", "url": "https://questionsmedicales.fr/article/36484565", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/epi.17483" } }, { "@type": "ScholarlyArticle", "name": "Part II: a step-by-step guide to latent class analysis.", "datePublished": "2022-06-01", "url": "https://questionsmedicales.fr/article/35662622", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jclinepi.2022.05.009" } }, { "@type": "ScholarlyArticle", "name": "Comorbidity profiles of patients experiencing homelessness: A latent class analysis.", "datePublished": "2022-05-24", "url": "https://questionsmedicales.fr/article/35609060", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0268841" } }, { "@type": "ScholarlyArticle", "name": "Life goal selection pattern and purpose in adolescence: A latent class analysis.", "datePublished": "2023-06-22", "url": "https://questionsmedicales.fr/article/37345900", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jad.12209" } }, { "@type": "ScholarlyArticle", "name": "Patterns of polysubstance use among adults in Malaysia-A latent class analysis.", "datePublished": "2023-01-17", "url": "https://questionsmedicales.fr/article/36649298", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0264593" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Métalloprotéines", "item": "https://questionsmedicales.fr/mesh/D008667" }, { "@type": "ListItem", "position": 5, "name": "Protéines de liaison au fer", "item": "https://questionsmedicales.fr/mesh/D033862" }, { "@type": "ListItem", "position": 6, "name": "Protéines à fer non hème", "item": "https://questionsmedicales.fr/mesh/D019159" }, { "@type": "ListItem", "position": 7, "name": "Lipoxygénases", "item": "https://questionsmedicales.fr/mesh/D058945" }, { "@type": "ListItem", "position": 8, "name": "Arachidonate lipoxygenases", "item": "https://questionsmedicales.fr/mesh/D001091" }, { "@type": "ListItem", "position": 9, "name": "Arachidonate 12-lipoxygenase", "item": "https://questionsmedicales.fr/mesh/D001092" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Arachidonate 12-lipoxygenase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Arachidonate 12-lipoxygenase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Arachidonate 12-lipoxygenase", "description": "Comment diagnostiquer une dysfonction de l'arachidonate 12-lipoxygenase ?\nQuels marqueurs biochimiques sont associés à cette enzyme ?\nY a-t-il des tests génétiques pour l'arachidonate 12-lipoxygenase ?\nQuels symptômes peuvent indiquer un problème avec cette enzyme ?\nComment l'imagerie peut-elle aider dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Arachidonate 12-lipoxygenase", "description": "Quels sont les symptômes d'une suractivité de l'enzyme ?\nL'arachidonate 12-lipoxygenase est-elle liée à des maladies spécifiques ?\nQuels signes cliniques peuvent indiquer une déficience ?\nComment l'inflammation se manifeste-t-elle cliniquement ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Arachidonate 12-lipoxygenase", "description": "Comment prévenir les troubles liés à l'enzyme ?\nY a-t-il des exercices recommandés ?\nLe stress a-t-il un impact sur l'activité de l'enzyme ?\nDes suppléments peuvent-ils aider à la prévention ?\nLa gestion du poids est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Arachidonate 12-lipoxygenase", "description": "Quels traitements ciblent l'arachidonate 12-lipoxygenase ?\nLes anti-inflammatoires non stéroïdiens sont-ils efficaces ?\nY a-t-il des thérapies alternatives recommandées ?\nComment la diététique influence-t-elle l'activité de l'enzyme ?\nLes corticostéroïdes sont-ils utilisés dans ce contexte ?", "url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Arachidonate 12-lipoxygenase", "description": "Quelles complications peuvent survenir avec une suractivité de l'enzyme ?\nL'arachidonate 12-lipoxygenase est-elle liée au cancer ?\nComment les maladies auto-immunes sont-elles liées à cette enzyme ?\nDes troubles neurologiques peuvent-ils être associés ?\nQuels effets à long terme peut avoir une inflammation chronique ?", "url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Arachidonate 12-lipoxygenase", "description": "Quels facteurs de risque sont associés à une dysfonction de l'enzyme ?\nL'hérédité joue-t-elle un rôle dans les troubles liés à l'enzyme ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress chronique influence-t-il l'activité de l'enzyme ?\nLes infections fréquentes sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D001092?mesh_terms=Latent+Class+Analysis&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction de l'arachidonate 12-lipoxygenase ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des analyses biochimiques peuvent évaluer l'activité de l'enzyme." } }, { "@type": "Question", "name": "Quels marqueurs biochimiques sont associés à cette enzyme ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les produits de dégradation des acides gras, comme les leucotriènes, peuvent être mesurés." } }, { "@type": "Question", "name": "Y a-t-il des tests génétiques pour l'arachidonate 12-lipoxygenase ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests génétiques peuvent identifier des mutations affectant l'enzyme." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec cette enzyme ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes inflammatoires, comme des douleurs articulaires, peuvent survenir." } }, { "@type": "Question", "name": "Comment l'imagerie peut-elle aider dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut détecter des inflammations ou des lésions associées à des troubles métaboliques." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une suractivité de l'enzyme ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une suractivité peut entraîner des inflammations chroniques et des douleurs." } }, { "@type": "Question", "name": "L'arachidonate 12-lipoxygenase est-elle liée à des maladies spécifiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est impliquée dans des maladies comme l'asthme et l'arthrite." } }, { "@type": "Question", "name": "Quels signes cliniques peuvent indiquer une déficience ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une susceptibilité accrue aux infections peuvent apparaître." } }, { "@type": "Question", "name": "Comment l'inflammation se manifeste-t-elle cliniquement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des rougeurs, des gonflements et des douleurs localisées." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de comorbidités." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés à l'enzyme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir les troubles." } }, { "@type": "Question", "name": "Y a-t-il des exercices recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des exercices réguliers peuvent améliorer la santé globale et réduire l'inflammation." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur l'activité de l'enzyme ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber l'inflammation et affecter l'activité enzymatique." } }, { "@type": "Question", "name": "Des suppléments peuvent-ils aider à la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des suppléments d'oméga-3 peuvent contribuer à une meilleure régulation de l'enzyme." } }, { "@type": "Question", "name": "La gestion du poids est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir un poids santé peut réduire le risque d'inflammation chronique." } }, { "@type": "Question", "name": "Quels traitements ciblent l'arachidonate 12-lipoxygenase ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des inhibiteurs spécifiques de l'enzyme peuvent être utilisés pour réduire l'inflammation." } }, { "@type": "Question", "name": "Les anti-inflammatoires non stéroïdiens sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire l'inflammation en inhibant la voie de l'acide arachidonique." } }, { "@type": "Question", "name": "Y a-t-il des thérapies alternatives recommandées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies comme l'acupuncture ou les oméga-3 peuvent aider à gérer les symptômes." } }, { "@type": "Question", "name": "Comment la diététique influence-t-elle l'activité de l'enzyme ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en acides gras oméga-3 peut moduler l'activité de l'enzyme." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils utilisés dans ce contexte ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent prescrits pour réduire l'inflammation associée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une suractivité de l'enzyme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des maladies cardiovasculaires et des troubles respiratoires peuvent survenir." } }, { "@type": "Question", "name": "L'arachidonate 12-lipoxygenase est-elle liée au cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surproduction de produits lipoxygénés peut être associée à certains cancers." } }, { "@type": "Question", "name": "Comment les maladies auto-immunes sont-elles liées à cette enzyme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une dysrégulation de l'enzyme peut contribuer à l'aggravation des maladies auto-immunes." } }, { "@type": "Question", "name": "Des troubles neurologiques peuvent-ils être associés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études suggèrent un lien entre l'activité de l'enzyme et certains troubles neurologiques." } }, { "@type": "Question", "name": "Quels effets à long terme peut avoir une inflammation chronique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une inflammation chronique peut entraîner des dommages tissulaires et des maladies dégénératives." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés à une dysfonction de l'enzyme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'obésité, le tabagisme et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans les troubles liés à l'enzyme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies inflammatoires peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut contribuer à l'inflammation et à la dysfonction enzymatique." } }, { "@type": "Question", "name": "Le stress chronique influence-t-il l'activité de l'enzyme ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber l'inflammation et affecter l'activité de l'enzyme." } }, { "@type": "Question", "name": "Les infections fréquentes sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections répétées peuvent perturber l'équilibre immunitaire et affecter l'enzyme." } } ] } ] }

Sources (10000 au total)

Latent class analysis of eHealth behaviors among adults with epilepsy.

The objective of this study was to determine the proportions of uptake and factors associated with electronic health (eHealth) behaviors among adults with epilepsy.... The 2013, 2015, and 2017 National Health Interview Surveys were analyzed. We assessed the proportions of use of five domains of eHealth in those with epilepsy: looked up health information on the inte... There were 1770 adults with epilepsy, of whom 65.87% had at least one eHealth behavior in the prior year. By domain, 62.61% looked up health information on the internet, 15.81% filled a prescription o... A majority of persons with epilepsy were found to use at least one form of eHealth. Various technological and demographic factors were associated with eHealth behaviors. Individuals with lower eHealth...

Life goal selection pattern and purpose in adolescence: A latent class analysis.

This study aims to investigate the goal selection patterns among adolescents and examines the extent to which goals focused on oneself, relationships, and the larger community were associated with var... Participants were 213 high school students with an average age of 15.18 years in an urban public school district in the Northeast United States. Students were asked to select their three most importan... A model with four classes (Self and Inner Circle, Inner Circle, Other-Oriented, and Self-Oriented) best fits the data. There were no statistical group differences in the variability of daily purpose a... Findings from this study provide a lens into goal prioritization patterns among adolescents. Further, although students who were more likely to select other-oriented goals had somewhat higher percepti...

Patterns of polysubstance use among adults in Malaysia-A latent class analysis.

Polysubstance use is the use of more than one non-prescribed licit or illicit substance at one time. This is a common phenomenon, but little is known about the severity and the various substances used... To determine the pattern of polysubstance use and its associated factors among general adults in Malaysia.... This was a secondary data analysis from the National Health and Morbidity Survey (NHMS) 2019), a cross-sectional population survey with a two-stage stratified random sampling design. A total of 10,472... Fit indices (AIC = 16458.9, BIC = 16443.6) from LCA supported 3 classes solution: Class 1; "moderate-drug" group primarily combination used of tobacco and alcohol (2.4%), Class 2; "high-drug" group us... Our study highlights patterns and demographics related to the use of polysubstances among adults in Malaysia. These results would help formulate specific prevention programmes for these high-risk grou...

Health risk factors in Australian Stroke Survivors: A latent class analysis.

To (i) determine the prevalence of health risk factors (physical activity, diet, alcohol, smoking, blood pressure medication use and mental health) in community-dwelling stroke survivors; and (ii) exa... A secondary analysis of data obtained during a national randomised controlled trial. Participants had experienced stroke and completed a baseline telephone survey on demographic and stroke characteris... Data analysed from 399 participants. Two classes of health risk factors were identified: Low Mood, Food & Moves Risk (16% of participants) and Alcohol Use Risk (84% of participants). The Low Mood, Foo... We identified two distinct health risk factor groups in our population. SO WHAT?: Future interventions may benefit from targeting the specific needs and requirements of people who have experienced str...

Latent Class Analysis of Prenatal Substance Exposure and Child Behavioral Outcomes.

To predict behavioral disruptions in middle childhood, we identified latent classes of prenatal substance use.... As part of the Environmental influences on Child Health Outcomes Program, we harmonized prenatal substance use data and child behavior outcomes from 2195 women and their 6- to 11-year-old children acr... Three latent classes fit the data: low use (90.5%; n = 1986), primarily using no substances; licit use (6.6%; n = 145), mainly using nicotine with a moderate likelihood of using alcohol and marijuana;... The differences in prenatal polysubstance use may increase risk for specific childhood problem behaviors; however, child outcomes appeared comparably adverse for both licit and illicit polysubstance e...